Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Finanšu pārskati |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-03-11 15:50:48 |
Versijas komentārs | |
Teksts |
Olainfarm Holds Fourth Quarter 2013 Investor Conference Webinar
AS „Olainfarm” invites shareholders, investors, mass media
representatives and other stakeholders to join its fourth quarter
2013 investor conference webinar scheduled on March 11, 2014 at
16:00 (EET).
Webinar will be hosted by the member of the management board Salvis
Lapiņš. The presentation will be in English.
During the webinar topics in relation to AS “Olainfarm” latest
activities and analysis of fourth quarter 2013 financial results
will be discussed.
What is webinar?
How to join the webinar?
Additional information on the webinar
The enclosed presentation will be presented during the
webinar.
A/s
OlainFarm is one of the biggest pharmaceutical companies in Latvia
with 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 30 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia.
Information
prepared by:
|
Pielikumi |